Khalpey AI Lab Partners With Biogenysis to Predict and Prevent Alzheimer’s Disease
(Synopsis)
Biogenysis, a subsidiary of Enzolytics, has partnered with Khalpey AI Lab in an effort to uncover biomarkers for early-onset Alzheimer's disease. This debilitating illness affects people of all ages, making...
Read moreDetails

















































